Editors in Conversation

Editors in Conversation

American Society for Microbiology
Country USA
Language EN
Episodes 123
Latest 13.11.2026

Editors in Conversation is the official podcast of the American Society for Microbiology Journals. In each episode, ASM Journals editors talk with researchers and clinicians about the most current topics in the microbial sciences. Recurring subjects include laboratory diagnosis and clinical treatment of infectious diseases, antimicrobial resistance, epidemiology, multidrug-resistant organisms, antimicrobial pharmacology and susceptibility testing. The show is aimed at microbiologists, infectious diseases clinicians, pharmacists and basic, clinical and translational researchers.

Episodes

  • The State of AMR: Gram-Negative/Positive Resistance and Pipeline Challenges
    The State of AMR: Gram-Negative/Positive Resistance and Pipeline Challenges 13.11.2026 39m
    Multidrug-resistant infections remain one of the most urgent public health challenges worldwide, with some infections approaching the limits of available treatment options. CDC just released their latest report that indicates that AMR is likely to kill more than 50,000 people a year in the US alone. Dr. William Miller's broad expertise in AMR makes him the perfect fit as an editor of the Antimicrobial Agents and Chemotherapy Journal and will reflect in this episode on the major challenges of the future of AMR in a complex and rapidly changing field. Topics discussed: The current state of AMR T...
  • Ebola: Is Your Laboratory Prepared To Handle a Potential Case?
    Ebola: Is Your Laboratory Prepared To Handle a Potential Case? 02.10.2026 48m
    An outbreak of Ebola disease caused by the Bundibugyo virus remains in a period of intense transmission, in the Democratic Republic of the Congo. Since it's first detection in May, 6757 cases have been confirmed across 6 provinces of the DRC, along with 20 cases in Uganda and one in France (as of September 8). A crude case fatality ratio of 48% underscores the severity of the disease and the ongoing challenges towards case detection, clinical care and, ultimately, interruption of transmission. Unchecked transmission of Bundibugyo in the DRC heightens the risk of exportation across internationa...
  • Group B Strep After Antibiotics: Survival, Persistence, and Evolution
    Group B Strep After Antibiotics: Survival, Persistence, and Evolution 18.09.2026 41m
    In this episode of Editors in Conversation mBio edition, Marvin Whiteley speaks with Macy Pell and Shannon Manning about how group B Streptococcus (GBS) responds to antibiotics given during childbirth to prevent newborn infections. GBS can cause serious neonatal disease, and intrapartum antibiotic prophylaxis has greatly reduced early-onset infections. But some GBS strains persist after treatment. The conversation explores a recent mBio study comparing GBS isolates collected from the same individuals before and after antibiotic treatment and childbirth. Rather than simply acquiring new resista...
  • Diagnostic Access and Equity
    Diagnostic Access and Equity 28.08.2026 45m
    Equitable access to healthcare, and more specifically diagnostic testing, remains elusive globally, negatively impacting the health and wellbeing of all people. A not-so-distant illustration was access to testing during the COVID-19 pandemic, when testing sites globally, including here in the United States, underserved the very populations who bore a disproportionate burden of COVID-19 cases and deaths. There is a tremendous opportunity for research on diagnostic access, as well as the epidemiology and diseases that impact underrepresented groups, in clinical microbiology. In 2026, JCM launche...
  • Gram-Negative Resistance: A Decade of Evolution with Laurent Poirel, Ph.D.
    Gram-Negative Resistance: A Decade of Evolution with Laurent Poirel, Ph.D. 08.08.2026 43m
    Multidrug-resistant Gram-negative infections remain one of the most urgent public health challenges worldwide, with some infections approaching the limits of available treatment options. In this special edition of Editors in Conversation, we celebrate the remarkable 10-year tenure of Dr. Laurent Poirel, whose pioneering work has profoundly shaped our understanding of antimicrobial resistance. Through his unique perspective, we will explore the evolving landscape of resistance in Gram-negative organisms, reflect on the major advances and challenges of the past decade, and discuss what the futur...
  • Technology and Discovery in Modern Microbiology
    Technology and Discovery in Modern Microbiology 31.07.2026 30m
    New imaging and measurement approaches are revealing previously hidden aspects of microbial life, challenging long-held assumptions and creating opportunities to answer questions that were once out of reach. Marvin Whiteley, Heran Darwin and Jeffrey Moffitt talk about how technological innovation is transforming microbiology. Guests: Heran Darwin, Ph.D. - NYU Grossman School of Medicine Jeffrey Moffitt, Ph.D. - Boston Children's Research This episode of Editors in Conversation is brought to you by mBio® and hosted by mBio Editor in Chief, Marvin Whiteley, Ph.D. Visit journals.asm.org/journal/m...
  • Cyclospora In The Lab
    Cyclospora In The Lab 19.07.2026 28m
    It starts out with a couple of stomach twinges, maybe a little nausea, maybe some sharp pains, and then… before you know it, you are running to the closest toilet with which you become very, very familiar. Cyclospora causes frequent watery diarrhea with sometime "explosive" bowel movements, but is typically a relatively rare cause of infectious diarrhea. However, the U.S. is in the midst of one of the largest documented cyclosporiasis outbreaks. How does one acquire this parasite? What are the risks? And – most importantly for our audience – how does the lab approach diagnosis? Guests: Daniel...
  • Next Gen Careers in Clinical Microbiology
    Next Gen Careers in Clinical Microbiology 10.07.2026 29m
    So, you think you want a career in clinical microbiology? This field demands more than technical skill—it's driven by curiosity, growth, and the confidence to lead. From mastering diagnostics to pushing innovation and mentoring the next generation, success comes to those who keep evolving. In this episode, we explore the many paths into the field—and spotlight the Laboratory Director role through a candid conversation between early- and mid-career leaders, sharing the real highs, lows, and advice for those ready to step up. Watch this episode: https://youtu.be/p992HyDcm-M Guests: Amanda Roth,...
  • AI and Antibiotic Discovery
    AI and Antibiotic Discovery 01.07.2026 43m
    Artificial intelligence is revolutionizing the world in many ways. One of the most exciting applications of artificial intelligence is in the area of drug discovery. Particularly the discovery of antimicrobial molecules that are in the environment or even hidden within our own body. Today, we discuss some of the uses of artificial intelligence in the discovery of antimicrobials with an outstanding expert in the field. Topics discussed: How artificial intelligence can help the discovery of new antimicrobial moieties Antibiotic discovery and challenges to bring molecules to the clinic The implic...
  • Why Your Lab QC Might Be Missing Critical Errors
    Why Your Lab QC Might Be Missing Critical Errors 24.04.2026 40m
    Accurate AST results are the backbone of diagnostic stewardship, yet routine quality control (QC) might be missing subtle shifts that skew your hospital's annual antibiogram. By examining a real-world "silent failure" in daptomycin testing, we explore how lab-driven data is essential to the AMR crisis response and why the human eye—and traditional QC bugs—aren't always enough to catch technical drifts. This session breaks down the importance of LIS rules, alert fatigue, and the future of automated susceptibility testing. Guests: Laurel J. Glaser, M.D., Ph.D. Rebekah Dumm, Ph.D. D(ABMM) Links:...
  • Phage JS1: The Virus Breaking the Rules
    Phage JS1: The Virus Breaking the Rules 11.04.2026 40m
    In this episode, a fascinating new bacteriophage, JS1. While most contractile phages (which inject DNA like a spring-loaded syringe) are rigid and straight, JS1 sports a curved, flexible tail that may help it navigate the complex "canyons and valleys" of the bacterial cell wall. Watch this episode: https://youtu.be/eDGta8xc4_0 Guests: Sabrina Suhani, Ph.D., Graduate Student, Monash University, Australia Trevor Lithgow, Ph.D., Professor, Monash University's Biomedical Discovery Institute. Links: Staphylococcus species infected by a bacteriophage with a tail that is both curved and contractile T...
  • Urine-based Testing to Detect HPV
    Urine-based Testing to Detect HPV 27.03.2026 37m
    Is the future of cervical cancer screening non-invasive? Sharmila Manjeshwar, Ph.D. and Jeffrey Klausner M.D. MPH, discuss a breakthrough in HPV diagnostics: urine-based testing. While vaccination and clinical screening have reduced cervical cancer rates, participation has stalled due to barriers like healthcare access and the invasive nature of traditional clinician-collected samples. This conversation explores how novel high-volume urine concentration technology is changing the landscape, making screening more accessible, private, and efficient. Watch this episode: https://youtu.be/am7NvL1Y0...
  • The Aerobiome - The Hidden Biology of Air
    The Aerobiome - The Hidden Biology of Air 20.03.2026 37m
    Most microbiome research focuses on soil, oceans, or hosts. But the atmosphere itself harbors diverse communities of bacteria and fungi that move between ecosystems. This episode explores a recent mBio study comparing airborne microbial communities above a subalpine forest and a grassland in Colorado. The conversation unpacks what the "aerobiome" is, how scientists actually sample microbes from the air, and why height, time of day, and season matter. The study reveals striking differences between fungi and bacteria, with fungi showing strong site-specific structure and environmental sensitivit...
  • Harnessing MALDI-TOF for MICs
    Harnessing MALDI-TOF for MICs 06.03.2026 33m
    Matrix-assisted laser desorption ionization time of flight mass spectrometry (or MALDI) has revolutionized the clinical microbiology laboratory, enabling rapid, accurate and cheap identification of bacteria, yeast, moulds and mycobacteria. In most labs, it has become a verb (I maldi'ed it). But – can it replace our antimicrobial susceptibility tests? Let's find out! Guests: Dr. Frieder Schaumburg Niklas Wiesmann
  • Fungi in a Warming World: Climate, Candida auris, and the Next Microbial Frontier - with Arturo Casadevall, M.D., Ph.D.
    Fungi in a Warming World: Climate, Candida auris, and the Next Microbial Frontier - with Arturo Casadevall, M.D., Ph.D. 27.02.2026 44m
    In the inaugural episode of Editors in Conversation mBio edition, Marvin Whiteley speaks with Arturo Casadevall, infectious-disease physician-scientist, founding Editor in Chief of mBio, and a leading voice in fungal pathogenesis and scientific rigor. They explore how climate change may be reshaping the fungal kingdom, potentially eroding the thermal barrier that has historically protected humans from most fungal pathogens. Using Candida auris (C auris) as a case study, they discuss heat adaptation, antifungal resistance, and what climate change could mean for future outbreaks. The conversatio...
  • Best AMR papers of 2025: A Collaboration between AAC and JID for IMARI
    Best AMR papers of 2025: A Collaboration between AAC and JID for IMARI 07.02.2026 50m
    The Interdisciplinary Meeting of Antimicrobial Resistance and Innovation has launched! The first version of IMARI brought together researchers, clinicians, industry leaders and policymakers to address one of the greatest challenges in modern medicine: antimicrobial resistance" Check the highlights at IMARI.org and prepare for IMARI 2017 from January 27-29, 2027! The inaugural amazing conference took place in Las Vegas. This is the forst time that ASM and IDSA collaborate together in a scientific meeting. One of the sessions involved an unprecedent collaboration between two journals AAC and JID...
  • Green Labs
    Green Labs 25.01.2026 35m
    Climate change is one of the most pressing issues facing humanity – and is not a future problem. Changes to the Earth's climate driven by emission of greenhouse gases have led to glaciers shrinking, plant and animal geographic ranges shifting and historical droughts, wildfires and rainfall. What does all of this have to do with the clinical laboratory? Subscribe to Editors in Conversation on Apple Podcasts, Android, Spotify, or Email and never miss an episode. Guests: Dr. Joesph Wiencek, Director of Clinical Chemistry and Associate Professor at VUMC Andrea Prinzi, Ph.D., MPH, SM(ASCP), bioMéri...
  • Rising Antimicrobial Resistance in The Microbial Universe
    Rising Antimicrobial Resistance in The Microbial Universe 09.01.2026 56m
    This is a special live recording of Editors in Conversation at the 2025 ASM Global Research Symposium in Bengaluru, India. We explore the evolving landscape of drug-resistant pathogens—from the intracellular survival strategies of Salmonella to the global rise of multidrug-resistant fungi like Candida auris. This conversation highlights the urgent need for integrated, One Health solutions to combat AMR across human, animal, and environmental domains. Watch this episode: https://youtu.be/G1KtS6MSjHs Topics discussed: The implications of the OneHealth approach for microbiology and public health....
  • Favorite Clinical Microbiology Papers of 2025
    Favorite Clinical Microbiology Papers of 2025 19.12.2025 58m
    I almost can't believe that we are wrapping up yet another year on the podcast this month, which has been going strong for 6 years now! And it has been another exciting year in the world of Clin Micro as well with improvements and new assays available for some of our bread and butter tests, but the year also brought about significant developments in the application of AI and digital imaging, use of NGS methods, and probably some cool AST stuff in there too among other things, with many of these advancements published in JCM. And so, as has become customary for the last 6 years, for this episod...
  • Clinical Trials With the Potential To Change the Management of Prosthetic Joint Infections
    Clinical Trials With the Potential To Change the Management of Prosthetic Joint Infections 06.12.2025 47m
    Prosthetic joint infections (PJI) remain among the most devastating complications in orthopedic surgery, with increasing incidence paralleling the growth in arthroplasty procedures worldwide. While treatment protocols are well-established, evidence supporting current approaches is lacking, and outcomes remain suboptimal, highlighting the need for improved therapeutic strategies. AAC recently published a minireview of randomized controlled trials and emerging evidence for the management for these difficult to treat infection. Today, we discuss with one of the authors of the manuscript and an ID...

Popular in

The podcast also appears in the podcast charts of these countries.